Effects of glucagon‐like peptide‐1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta‐analysis of randomized controlled trials

Documents similaires

• Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes
  par: Djordje S. Popovic, et autres
  Publié: (2024)
• And the Dog Was Barking: Transforming Quality of Life in Diabetes Through Innovative Hypoglycemia Detection
  par: Theocharis Koufakis, et autres
  Publié: (2025)
• Has the time come for a remission definition in type 1 diabetes? A functional perspective
  par: Djordje S. Popovic, et autres
  Publié: (2026)
• Current treatment guidelines and glycated haemoglobin goals for type 2 diabetes: Which patients are most likely to benefit from fixed‐ratio basal insulin glucagon‐like peptide‐1 receptor agonist combinations?
  par: Kevin Cowart, et autres
  Publié: (2025)
• Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐ 1 receptor agonist therapy in insulin‐treated diabetes
  par: Irl B. Hirsch, et autres
  Publié: (2024)